BSX — Boston Scientific Corp · P/E 20, rev $20.07B

Boston Scientific Corp (BSX) is a medical devices company listed on US.

Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.

Use this BSX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BSX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BSX SEC filings page. Lician reads the product cache first so this HTML stays unique to Boston Scientific Corp even when a live quote feed is slow.